These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11849235)

  • 21. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
    Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
    Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma.
    McCann JC; Kanteti R; Shilepsky B; Miller KB; Sweet M; Schenkein DP
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):37-43. PubMed ID: 9078353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Frühauf S; Flentje M; Wannenmacher M; Hunstein W
    J Clin Oncol; 1994 Aug; 12(8):1685-92. PubMed ID: 7518860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma.
    Burchill SA; Kinsey SE; Picton S; Roberts P; Pinkerton CR; Selby P; Lewis IJ
    Med Pediatr Oncol; 2001 Jan; 36(1):213-9. PubMed ID: 11464888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of apoptosis and effect on CD20+ using rituximab on autologous peripheral blood stem cell harvests from patients with B cell lymphomas.
    Borbolla-Escoboza JR; Leon MI; Collados MT; Baez E; Baltasar S; Hernández R; Rojas JC
    Stem Cells Dev; 2004 Apr; 13(2):193-6. PubMed ID: 15186735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?
    Jacquy C; Lambert F; Soree A; Van Daele S; Heusterspreute M; Bosly A; Ferrant A; Parma J; Bron D; Martiat P
    Bone Marrow Transplant; 1999 Apr; 23(7):681-6. PubMed ID: 10218844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation.
    Demirkazik A; Kessinger A; Armitage JO; Bierman PJ; Lynch J; Vose J; Chan W; Sharp JG
    Bone Marrow Transplant; 2001 Jul; 28(2):207-12. PubMed ID: 11509940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
    Lazzarino M; Arcaini L; Bernasconi P; Alessandrino EP; Gargantini L; Cairoli R; Orlandi E; Astori C; Brusamolino E; Pagnucco G; Colombo AA; Calatroni S; Iacona I; Regazzi MB; Morra E
    Br J Haematol; 2002 Jan; 116(1):229-35. PubMed ID: 11841421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    Dreger P; von Neuhoff N; Kuse R; Sonnen R; Glass B; Uharek L; Schoch R; Löffler H; Schmitz N
    Br J Cancer; 1998 Jun; 77(12):2291-7. PubMed ID: 9649148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid two-step method for elimination of bcl-2/IgH positive non-Hodgkin's lymphoma cells from human blood or marrow stem cells, employing immunomagnetic purging with streptavidin-coated ferrofluids.
    Mangan KF; Leonardo J; Mullaney MT; Terstappen LW; Rao C; Liberti P
    Cytotherapy; 1999; 1(4):287-93. PubMed ID: 20426554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
    Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
    Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.
    Burgess J; Mills B; Griffith M; Mansour V; Weaver CH; Schwartzberg LS; Snyder EL; Krause DS; Yanovich S; Prilutskaya M; Umiel T; Moss TJ
    Cytotherapy; 2001; 3(4):285-94. PubMed ID: 12171717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
    Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
    J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.
    Paulus U; Dreger P; Viehmann K; von Neuhoff N; Schmitz N
    Stem Cells; 1997; 15(4):297-304. PubMed ID: 9253114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
    Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
    Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.